AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,893,000 | +14.0% | 201,352 | -7.2% | 0.00% | 0.0% |
| Q2 2020 | $1,660,000 | +28.2% | 216,919 | +3.6% | 0.00% | 0.0% |
| Q1 2020 | $1,295,000 | -48.2% | 209,446 | +1.9% | 0.00% | 0.0% |
| Q4 2019 | $2,502,000 | +7.7% | 205,514 | +2.1% | 0.00% | 0.0% |
| Q3 2019 | $2,324,000 | -9.0% | 201,195 | -21.3% | 0.00% | -50.0% |
| Q2 2019 | $2,553,000 | -39.8% | 255,509 | -22.4% | 0.00% | -33.3% |
| Q1 2019 | $4,241,000 | -30.2% | 329,267 | -17.6% | 0.00% | -40.0% |
| Q4 2018 | $6,072,000 | -28.8% | 399,678 | -6.3% | 0.01% | -16.7% |
| Q3 2018 | $8,529,000 | +7.3% | 426,424 | +4.7% | 0.01% | 0.0% |
| Q2 2018 | $7,946,000 | +5.8% | 407,464 | +9.3% | 0.01% | 0.0% |
| Q1 2018 | $7,509,000 | +26.7% | 372,631 | -16.7% | 0.01% | +20.0% |
| Q4 2017 | $5,928,000 | -24.4% | 447,363 | +5.3% | 0.01% | -28.6% |
| Q3 2017 | $7,839,000 | +46.5% | 424,875 | +46.1% | 0.01% | +40.0% |
| Q2 2017 | $5,351,000 | -21.6% | 290,795 | -4.0% | 0.01% | -28.6% |
| Q1 2017 | $6,828,000 | -54.8% | 302,768 | -30.3% | 0.01% | -58.8% |
| Q4 2016 | $15,112,000 | +44.5% | 434,227 | +1.8% | 0.02% | +41.7% |
| Q3 2016 | $10,459,000 | +7.4% | 426,699 | +4.8% | 0.01% | 0.0% |
| Q2 2016 | $9,741,000 | +2.7% | 407,221 | +0.5% | 0.01% | 0.0% |
| Q1 2016 | $9,485,000 | -26.1% | 405,329 | -4.7% | 0.01% | -29.4% |
| Q4 2015 | $12,837,000 | -20.9% | 425,204 | +4.1% | 0.02% | -29.2% |
| Q3 2015 | $16,224,000 | -6.8% | 408,334 | +61.9% | 0.02% | 0.0% |
| Q2 2015 | $17,416,000 | +268.1% | 252,180 | +191.4% | 0.02% | +242.9% |
| Q1 2015 | $4,731,000 | +97.2% | 86,535 | +53.8% | 0.01% | +75.0% |
| Q4 2014 | $2,399,000 | -41.7% | 56,281 | -56.3% | 0.00% | -42.9% |
| Q3 2014 | $4,115,000 | +43.7% | 128,929 | -6.7% | 0.01% | +40.0% |
| Q2 2014 | $2,863,000 | +6.7% | 138,168 | -0.3% | 0.01% | 0.0% |
| Q1 2014 | $2,682,000 | -48.7% | 138,568 | -35.7% | 0.01% | -50.0% |
| Q4 2013 | $5,229,000 | +1.3% | 215,438 | -8.8% | 0.01% | -9.1% |
| Q3 2013 | $5,160,000 | -10.5% | 236,248 | -8.4% | 0.01% | -15.4% |
| Q2 2013 | $5,767,000 | – | 258,013 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |